Sixth annual RNA Center Symposium to explore future of RNA therapeutics
The stunning success of mRNA vaccines in preventing severe disease and death from the coronavirus has many wondering what other biomedical applications might result from RNA research.
The U-M Center for RNA Biomedicine will deeply explore this question at its sixth annual symposium on March 25, entitled, “Towards our Future of RNA Therapeutics.”
RNA research currently shapes revolutionary scientific paths, from fundamental science discoveries in the labs to powerful biomedical applications for patients. Five renowned keynote speakers will illuminate the emerging future of RNA therapeutics.
They are in order of their talks:
- Nobel Laureate Jack Szostak, Harvard University, on the origin of life.
- Gisela Storz, National Institutes of Health, on small regulatory RNAs.
- Chris Burge, Massachusetts Institute of Technology, on pre-mRNA splicing.
- John Rinn, University of Colorado, on IncRNAs in human health and disease.
- Michele Hastings, Rosalind Franklin University, on RNA therapeutics.
The symposium also features six mini-talks by U-M researchers and concludes with a panel discussion moderated by U-M alum John Androsavich, Global Lead of RNA Medicine at Pfizer. It is the formal launch of a new thrust of the Center for RNA Biomedicine in “M-RNA Therapeutics.”
The event will be in person and will be live streamed via Zoom, but not recorded.
It begins at 8:30 a.m. in the Kahn auditorium of the A. Alfred Taubman Biomedical Research Science Building. It is free and open to all, although registration is required. Register at rna.umich.edu/2022-symposium. A boxed lunch will be provided.
Since its inception in 2016, the Center for RNA Biomedicine fosters and promotes the U-M RNA research community. Funded as part of the Presidential Biosciences Initiative in 2018, the center has organized an annual symposium to bring the RNA research community together to discuss the latest discoveries in the field and the next scientific inquiries.
The Center for RNA Biomedicine is the largest academic RNA research center in the United States. It comprises more than 150 faculty and their labs, across seven schools and colleges of the Ann Arbor campus, reflecting the interdisciplinary requirement and collaborative spirit of RNA research.